Your session is about to expire
← Back to Search
Dietary Supplement
Nutrition Supplements for Trauma Recovery in Older Adults (SeND Home Trial)
N/A
Waitlist Available
Led By Krista Haines, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing if giving older trauma patients extra nutrition shakes helps them recover better. The patients will get these shakes in the hospital and for some time after leaving. Researchers will check their energy use, body composition, muscle mass, and overall quality of life.
Who is the study for?
This trial is for trauma patients who are at least 60 years old and admitted to the trauma service, with a standard care CT scan done. It's not for non-English speakers, pregnant individuals, prisoners, those expected to withdraw from life-sustaining treatment within 48 hours, anyone unable to consent or allergic to milk/soy.
What is being tested?
The study compares SeND Home precision nutrition pathway (Ensure shakes up to three times daily in hospital and four weeks post-discharge) against normal nutrition recommendations by clinical providers. Participants will be randomly assigned in a ratio of 3:1 favoring the SeND Home group.
What are the potential side effects?
Potential side effects may include reactions related to milk or soy allergies due to ingredients in Ensure shakes. Other general risks could involve discomfort from non-invasive tests measuring energy use, body composition, and muscle mass.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Feasibility of SeND Home pathway
Secondary study objectives
Acceptability of SeND Home pathway
Fidelity of SeND Home pathway
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: SeND Home precision nutrition pathwayExperimental Treatment1 Intervention
Oral nutrition supplements (ONS) will be given, at maximum, three times per day throughout hospitalization. Upon discharge, participants will be given 4-weeks' worth of oral supplements to take. Adjustments may be made based on indirect calorimetry (IC) measurements by the clinical dietitian.
Group II: Control pathwayActive Control1 Intervention
Standard of care nutrition delivery throughout hospitalization. Upon discharge they will be sent home with standard nutrition information without Indirect Calorimetry (IC) guidance.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nutrition supplement - Ensure shakes
2023
N/A
~40
Find a Location
Who is running the clinical trial?
Duke UniversityLead Sponsor
2,451 Previous Clinical Trials
3,067,030 Total Patients Enrolled
Krista Haines, MDPrincipal InvestigatorDuke University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am unable to understand and agree to the study's details on my own.I have had a traumatic brain injury.I am 60 or older and have been admitted for trauma care.
Research Study Groups:
This trial has the following groups:- Group 1: SeND Home precision nutrition pathway
- Group 2: Control pathway
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger